(Q38164656)

30 August 2017

Unleash metformin: reconsideration of the contraindication in patients with renal impairment (English)

1 reference

30 August 2017

1 reference

1 reference

Wenya R Lu

1

1 reference

30 August 2017

Jennifer Defilippi

series ordinal

2

1 reference

30 August 2017

Amy Braun

series ordinal

3

1 reference

30 August 2017

language of work or name

English

0 references

publication date

10 October 2013

1 reference

Annals of Pharmacotherapy

30 August 2017

1 reference

30 August 2017

47

1 reference

30 August 2017

11

1 reference

30 August 2017

1488-1497

1 reference

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

30 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F1060028013505428

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028013505428

Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028013505428

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028013505428

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028013505428

10-year follow-up of intensive glucose control in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028013505428

Long-term effects of metformin on metabolism and microvascular and macrovascular disease in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028013505428

Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028013505428

Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028013505428

Metformin-associated lactic acidosis: a rare or very rare clinical entity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028013505428

Metformin, heart failure, and lactic acidosis: is metformin absolutely contraindicated?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028013505428

Lactic acidosis rates in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028013505428

Incidence of lactic acidosis in metformin users

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028013505428

Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia: a nested case-control analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028013505428

Contraindications to metformin therapy in patients with Type 2 diabetes--a population-based study of adherence to prescribing guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028013505428

Severe acidosis in patients taking metformin--rapid reversal and survival despite high APACHE score

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028013505428

Contra-indications to metformin therapy are largely disregarded

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028013505428

Metformin and lactic acidosis: cause or coincidence? A review of case reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028013505428

Risk of Fatal and Nonfatal Lactic Acidosis With Metformin Use in Type 2 Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028013505428

Prescribing metformin in type 2 diabetes with a contraindication: prevalence and outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028013505428

Metformin use and mortality among patients with diabetes and atherothrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028013505428

Effectiveness and safety of metformin in 51 675 patients with type 2 diabetes and different levels of renal function: a cohort study from the Swedish National Diabetes Register

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028013505428

Metformin-associated lactic acidosis precipitated by acute renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028013505428

Kidney function and age are both predictors of pharmacokinetics of metformin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028013505428

Use of metformin in the setting of mild-to-moderate renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1060028013505428

21 January 2018

Identifiers

DOI

10.1177/1060028013505428

1 reference

30 August 2017

1 reference